v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Total revenue $ 1,488 $ 1,373 $ 3,022 $ 2,854
Operating expenses        
Research and development 10,690 8,402 21,945 17,932
General and administrative 7,242 6,766 15,359 13,218
Total operating expenses 17,932 15,168 37,304 31,150
Loss from operations (16,444) (13,795) (34,282) (28,296)
Interest income 395 227 526 571
Interest expense (4,476) (1,285) (5,796) (2,543)
Loss on extinguishment of debt (2,383) 0 (2,383) 0
Change in fair value of derivative liability (1,891) 0 (1,891) 0
Other (expense) income, net (78) 114 (228) 179
Total other (expense) income (8,433) (944) (9,772) (1,793)
Net loss (24,877) (14,739) (44,054) (30,089)
Other comprehensive income (loss)        
Foreign currency translation adjustment 49 (28) 152 (36)
Comprehensive loss (24,828) (14,767) (43,902) (30,125)
Net loss attributable to common shareholders — basic (24,877) (14,739) (44,054) (30,089)
Net loss attributable to common shareholders — diluted $ (24,877) $ (14,739) $ (44,054) $ (30,089)
Weighted shares used in calculating net loss per share - basic (in shares) 338,679,856 292,067,192 333,142,618 292,032,072
Weighted shares used in calculating net loss per share - diluted (in shares) 338,679,856 292,067,192 333,142,618 292,032,072
Net loss per share attributable to shareholders - basic (in USD per share) $ (0.07) $ (0.05) $ (0.13) $ (0.10)
Net loss per share attributable to shareholders - diluted (in USD per share) $ (0.07) $ (0.05) $ (0.13) $ (0.10)
Collaborative Arrangements        
Total revenue $ 1,488 $ 1,373 $ 3,022 $ 2,854
Operating expenses        
Research and development $ 400 $ 300 $ 1,300 $ 1,100